Home/Startups/Exobiosphere

Exobiosphere

VerifiedEarly stage
Space BiotechnologyDrug DiscoveryMicrogravity Research

Exobiosphere develops a standardized space-based high-throughput testing platform to accelerate drug discovery and biomedical R&D using microgravity environments.

Space BiotechnologyDrug DiscoveryMicrogravity ResearchHigh-Throughput TestingOrbital BiologyBiomedical R&DDisease Modeling
Esch-sur-Alzette1-10 employeesFounded EN
5/5 verified · 6 sources on record
Visit website
Work here? Verify ownership in ~2 min.

Free verification proves website control and lets the business keep this profile accurate.

OverviewAbout Exobiosphere

Exobiosphere aims to extend and improve life on Earth and in space by utilizing microgravity to accelerate drug discovery and develop therapies that are challenging to develop on Earth. The company operates the world's first standardized space-based high-throughput testing platform, enabling pharmaceutical and biotech partners to conduct automated experiments in orbit at scale. By integrating advanced lab automation and bioinformatics, it generates more physiologically relevant disease models to bring faster treatments to patients.

ProductsWhat Exobiosphere builds

Orbital High-Throughput System

Enables large-scale, automated testing in space to create unique disease models in microgravity for accelerated drug discovery.

Track recordMilestones & press

event

Featured company at Silicon Luxembourg's Startup Apéro #67 (February 2026)

award

Won a USD 1 million investment on Meet the Drapers (April 2026)

grant

ESA contract for microgravity research aboard Vast's Haven-1 space station (May 2026)

press

EUR 2M seed round led by Expansion Ventures covered by Silicon Luxembourg (April 2025)

funding

Raised EUR 2M (Seed), backed by Expansion Ventures, Expon Capital, Space Data

FundingPublicly reported rounds

Publicly reported funding rounds for Exobiosphere
YearRoundAmountInvestorsSource
SeedEUR 2MExpansion Ventures, Expon Capital, Space Dataen.paperjam.lu

amounts as reported in press coverage, not verified against filings

Knowledge baseQuestions people ask

What does Exobiosphere do?

Exobiosphere develops a standardized space-based high-throughput testing platform to accelerate drug discovery and biomedical R&D using microgravity environments.

Where is Exobiosphere based?

Exobiosphere is based in Esch-sur-Alzette, Luxembourg.

Who founded Exobiosphere?

Exobiosphere has three co-founders: Kyle Acierno (CEO), Dr Bruno Santos (Director of R&D) and Dr Olivia Borgue (Director of Engineering).

How much funding has Exobiosphere raised?

Exobiosphere closed a EUR 2 million seed round in April 2025, led by Expansion Ventures with participation from Expon Capital and Space Data.

What is Exobiosphere's ESA contract?

In May 2026, the European Space Agency contracted Exobiosphere for microgravity research to fly aboard Vast's Haven-1 space station.

What did Exobiosphere win on Meet the Drapers?

Exobiosphere won a USD 1 million investment on the Meet the Drapers show in April 2026.

These Q&A pairs are the company's static KB file: the records the chat/search deployment indexes to ground its answers.

ProvenanceEvery field, with its source

Open a source to inspect the evidence. Labels distinguish official records, company-published facts, third-party reporting, and derived values.

Provenance of each data field for Exobiosphere: value, source, and date checked
FieldValueSourceChecked
displayNameExobiosphereexobiosphere.comcompanyOwned
sectorSpace Biotechnology / Drug Discovery / Microgravity Researchexobiosphere.comcompanyOwned
legalNameExobiosphereLuxembourg Business Registers (RCS)official
rcsNumberB289021Luxembourg Business Registers (RCS)official
legalFormSARLLuxembourg Business Registers (RCS)official
registrationDate2024-09-05Luxembourg Business Registers (RCS)official
registeredOffice29, Rue Henri Koch, L-4354 Esch-sur-AlzetteLuxembourg Business Registers (RCS)official
founded2024Luxembourg Business Registers (RCS)official
teamSize1-10researcher note (source pending)pending·
stageearly (Seed EUR 2M led by Expansion Ventures (April 2025))derived from funding records and team size on filethirdParty
coordinates49.509315443, 5.965989325 (29, Rue Henri Koch, L-4354 Esch-sur-Alzette)Geoportail BD-Adressesofficial
linkedinhttps://www.linkedin.com/company/exobiospherelinkedin.comthirdParty
longDescription(about text)exobiosphere.comcompanyOwned
annualAccountspendingCentrale des Bilans queuedpending·
publicPresenceLinkedIn + 6 press/news sourceslinkedin.comthirdParty
logo/logos/exobiosphere.pngimages.squarespace-cdn.comthirdParty